Celularity（CELU.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他51.95%
上市公司21.91%
机构投资者13.23%
个人与内部人士12.24%
私营企业0.67%

主要股东

主要股东最新
股东
Genting Berhad	17.78%	514.74 万	0.07%	+0	2025/10/30
Robert HaririFounder, CEO & Chairman	9.86%	285.36 万	0.05%	-4,463.00	2026/04/13
Starr International Investments Limited	5.62%	162.81 万	0.02%	+0	2025/10/30
Bristol-Myers Squibb Company	4.13%	119.53 万	0.02%	+0	2025/02/07
C.V. Starr & Co., Inc.	2.64%	76.41 万	<0.01%	+0	2026/06/30
Vanguard Capital Management, LLC	2.42%	70.10 万	<0.01%	+0	2026/06/30
Peter DiamandisIndependent Director	0.93%	26.92 万	<0.01%	+0	2026/01/12
GX Sponsor LLC	0.66%	19.09 万	<0.01%	+0	2025/02/07
Geode Capital Management, LLC	0.58%	16.72 万	0.09%	-2.39 万	2026/06/30
Geoffrey Shiu LingIndependent Director	0.45%	13.10 万	<0.01%	+0	2026/01/12
Dean KehlerFormer Independent Director	0.45%	13.05 万	<0.01%	+0	2025/02/07
Citadel Advisors LLC	0.34%	9.91 万	0.34%	+9.91 万	2026/06/30
BlackRock, Inc.	0.26%	7.64 万	0.18%	-5.11 万	2026/06/30
State Street Investment Management	0.20%	5.78 万	<0.01%	+0	2026/06/30
Hudson River Trading LLC	0.20%	5.66 万	0.15%	+4.38 万	2026/06/30
David BeersFormer Chief Financial Officer	0.17%	4.85 万	<0.01%	+0	2025/10/30
Northern Trust Global Investments	0.15%	4.42 万	<0.01%	+0	2026/06/30
Diane ParksIndependent Director	0.14%	3.95 万	<0.01%	+0	2026/01/12
Biltmore Family Office, LLC	0.12%	3.50 万	<0.01%	+0	2026/06/30
HB Wealth Management, LLC	0.11%	3.19 万	0.03%	-8,500.00	2026/06/30